Asensus Surgical (ASXC)
(Delayed Data from AMEX)
$0.33 USD
+0.10 (41.40%)
Updated Jun 7, 2024 04:00 PM ET
After-Market: $0.33 0.00 (-0.60%) 7:58 PM ET
4-Sell of 5 4
F Value C Growth C Momentum F VGM
Brokerage Reports
Asensus Surgical, Inc. [ASXC]
Reports for Purchase
Showing records 1 - 20 ( 22 total )
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Asensus Signs LOI with KARL STORZ; Receives Acquisition Proposal; Downgrade to Neutral with $0.35 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance Procedure Volume Maintains Growth Trajectory; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance Trend Bodes Well For 2024; LUNA Development on Track; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Portfolio Expansion on Track; Placement Guidance Revised; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Key Takeaways From Our KOL Dinner with Dr. Steven McCarus on Asensus? Senhance
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance Adoption Continues to Grow; Placement Guidance Reiterated; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Procedure Volume Increase and Portfolio Expansion Bode well for Senhance Growth
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Investing For the Future; Lower PT to $2; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Executing Growth Strategy by Evolution; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
2022 Installation Goal Achieved; Record Procedure Volume; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Procedure Volumes Continue to Grow; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Procedure Volumes Continue to Grow; Lower PT to $3; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Record Number of Procedures in 1Q22; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance Continues to Improve and Grow; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Takeaways From our KOL Call on Senhance; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance - The Next Generation Robotic Surgery System
Provider: H.C. Wainwright & Co., Inc.
Analyst: Research Department
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Preliminary 4Q21 Results Bode Well for Continued Growth in 2022; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Top Line Growth, Japanese Adoption, and Procedure Volume Growth Signals Long-Term Sustainability; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S
Company: Asensus Surgical, Inc.
Industry: Medical - Instruments
Senhance Installations On a Roll; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: RAMAKANTH S